1. Academic Validation
  2. First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents

First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents

  • Bioorg Med Chem. 2007 May 15;15(10):3413-21. doi: 10.1016/j.bmc.2007.03.019.
Puranik Purushottamachar 1 Aakanksha Khandelwal Pankaj Chopra Neha Maheshwari Lalji K Gediya Tadas S Vasaitis Robert D Bruno Omoshile O Clement Vincent C O Njar
Affiliations

Affiliation

  • 1 Department of Pharmacology & Experimental Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201-1559, USA.
Abstract

A qualitative 3D pharmacophore model (a common feature based model or Catalyst HipHop algorithm) was developed for well-known natural product Androgen Receptor down-regulating agents (ARDAs). The four common chemical features identified included: one hydrophobic group, one ring aromatic group, and two hydrogen bond acceptors. This model served as a template in virtual screening of the Maybridge and NCI databases that resulted in identification of six new ARDAs (EC(50) values 17.5-212 microM). Five of these molecules strongly inhibited the growth of human prostate LNCaP cells. These novel compounds may be used as leads to develop Other novel anti-prostate Cancer agents.

Figures